Hong-yu Li, Ph.D., a researcher with the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences, has received a five-year, $1.27 million grant from the National Institutes of Health and the National Cancer Institute to work toward developing two treatment options for acute myeloid leukemia patients.
Li, a professor with the College of Pharmacy in the Pharmaceutics Department, leads the developmental therapeutics research program at the Cancer Institute.
The grant will fund a study called “Development of Potent, Selective, Non-Myelotoxic FLT3 Inhibitors that Retain Efficacy Against Common Mechanisms of Resistance.” Li will serve as a principal investigator.
Also principal investigators are Dr. Neil Shah from the University of California at San Francisco and John Kuriyan, Ph.D., from the University of California at Berkeley.
Sign up for Daily E-news
